Cannabis Science, Inc. - Adhering to scientific methodologies to
develop, produce, and commercialize phytocannabinoid based
pharmaceutical products
Cannabis Science Inc works with World Authorities on phytocannabinoid
science targeting critical illnesses. Adhering to scientific
methodologies to develop, produce, and commercialize phytocannabinoid
based pharmaceutical products.
CS-TATI-1
Data published in March by researchers at the Mount Sinai School of
Medicine found that cannabinoids inhibit TAT induced migration to TAT
via cannabinoid 2 receptors (CB2).
Cannabis ...
Â
Since 2011, we have seen apparent success in 4 skin cancer patients
who have self-administered CS-S/BCC-1 –cannabinoid based extracts
topically to their basal and squamous cell carcinomas....